investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Programming T Cell Fates for Therapeutic Use

Luca Gattinoni

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Together with Dr. Zehn's group we are exploring the role of microRNA-155 in CD8+ T cell responses

Related projects

H Leighton Grimes

Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias

Leukaemia

Pathology Hematology and hematologic malignancies

Jun J Yang

ARID5B and Disparities of Childhood Leukemia

Leukaemia

Hematology and hematologic malignancies

Mark Y Chiang

Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia

Leukaemia

Hematology and hematologic malignancies

Jerald Patrick Radich

The Genetics of Post-Transplant Relapse in Myeloid Malignancy

Leukaemia

Pathology

Monica J Justice

The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms

Leukaemia

Hematology and hematologic malignancies Pathology

Bruce R Blazar

Cytotoxic-T-Lymphocyte (CTL) Therapy of Acute Myeloid Leukemia (AML)

Leukaemia

Pathology Hematology and hematologic malignancies

Hamid Band

Tyrosine Kinase Regulation Via Protein Degradation

Leukaemia

Pathology Hematology and hematologic malignancies

Clark W Distelhorst

Bcl-2 Function on the Endoplasmic Reticulum

Leukaemia

Pathology Hematology and hematologic malignancies

Mary V. Relling

Center for Precision Medicine in Leukemia (CPML)

Leukaemia

Pathology